Published Mar. 12, 2019 3:37 PM
The COLONIZE trial investigate whether the administration of microbiota from healthy donors can treat or prevent diarrhea caused by the pathogenic bacterium Clostridoides difficile, which is a feared complication of antibiotic treatment.